Detalhe da pesquisa
1.
Anti-PD-1 therapy triggers Tfh cell-dependent IL-4 release to boost CD8 T cell responses in tumor-draining lymph nodes.
J Exp Med
; 221(4)2024 Apr 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-38417020
2.
Tumor-intrinsic sensitivity to the pro-apoptotic effects of IFN-γ is a major determinant of CD4+ CAR T-cell antitumor activity.
Nat Cancer
; 4(7): 968-983, 2023 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-37248395
3.
Dynamic CD8+ T Cell Cooperation with Macrophages and Monocytes for Successful Cancer Immunotherapy.
Cancers (Basel)
; 14(14)2022 Jul 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-35884605
4.
Preclinical murine tumor models: a structural and functional perspective.
Elife
; 92020 Jan 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-31990272
5.
Local IFNα enhances the anti-tumoral efficacy of systemic anti-PD1 to prevent tumor relapse.
J Immunother Cancer
; 8(2)2020 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-33239415
6.
The Remarkable Plasticity of Macrophages: A Chance to Fight Cancer.
Front Immunol
; 10: 1563, 2019.
Artigo
em Inglês
| MEDLINE | ID: mdl-31354719
7.
TGFß blocks IFNα/ß release and tumor rejection in spontaneous mammary tumors.
Nat Commun
; 10(1): 4131, 2019 09 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-31511510
8.
The STING agonist DMXAA triggers a cooperation between T lymphocytes and myeloid cells that leads to tumor regression.
Oncoimmunology
; 6(10): e1346765, 2017.
Artigo
em Inglês
| MEDLINE | ID: mdl-29123960